2024
Farrington, N., Dubey, V., Johnson, A., Horner, I., Stevenson, A., Unsworth, J., . . . Darlow, C. A. (2024). Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.. mBio, 15(2), e0316523. doi:10.1128/mbio.03165-23DOI: 10.1128/mbio.03165-23
2023
Dubey, V., Gupta, R., & Pathania, R. (2023). Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced <i>Acinetobacter baumannii</i> persisters.. Antimicrobial agents and chemotherapy, 95(5), AAC.02180-AAC.02120. doi:10.1128/aac.02180-20DOI: 10.1128/aac.02180-20
2022
Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections. (Journal article)
Dubey, V., Devnath, K., Gupta, V. K., Kalyan, G., Singh, M., Kothari, A., . . . Pathania, R. (2022). Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.. The Journal of antimicrobial chemotherapy, 77(5), 1313-1323. doi:10.1093/jac/dkac057DOI: 10.1093/jac/dkac057
2018
Sharma, A., Dubey, V., Sharma, R., Devnath, K., Gupta, V. K., Akhter, J., . . . Pathania, R. (2018). The unusual glycine-rich C terminus of the <i>Acinetobacter baumannii</i> RNA chaperone Hfq plays an important role in bacterial physiology.. The Journal of biological chemistry, 293(35), 13377-13388. doi:10.1074/jbc.ra118.002921DOI: 10.1074/jbc.ra118.002921